首页> Cancer management and research> EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10).

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10).

导出 LinkOut

翻译打印收藏纠错

第一作者： Sergio,Vázquez

第一单位： Medical Oncology Department, Lucus Augusti University Hospital, Lugo, Spain.

作者： Sergio,Vázquez ^[1] ; Joaquín,Casal ^[2] ; Francisco Javier,Afonso Afonso ^[3] ; José Luis,Fírvida ^[4] ; Lucía,Santomé ^[5] ; Francisco,Barón ^[6] ; Martín,Lázaro ^[7] ; Carolina,Pena ^[7] ; Margarita,Amenedo ^[8] ; Ihab,Abdulkader ^[9] ; Carmen,González-Arenas ^[10] ; Laura,Fachal ^[11] ; Ana,Vega ^[11]

作者单位： Medical Oncology Department, Lucus Augusti University Hospital, Lugo, Spain. ^[1] Medical Oncology Department, University Hospital Complex of Vigo, Pontevedra, Spain. ^[2] Medical Oncology Department, University Hospital Complex of Ferrol, Ferrol, Spain. ^[3] Medical Oncology Department, University Hospital Complex of Ourense, Ourense, Spain. ^[4] Medical Oncology Department Povisa Hospital, Vigo, Spain. ^[5] Medical Oncology Department, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain. ^[6] Medical Oncology Department, Hospital Complex of Pontevedra, Pontevedra, Spain. ^[7] Medical Oncology Department, Oncology Center of Galicia, A Coruña, Spain. ^[8] Anatomical Pathology Department, University Hospital Complex of Santiago de Compostela, Santiago de Compostela, Spain. ^[9] AstraZeneca, Madrid, Santiago de Compostela, Spain. ^[10] Galician Public Foundation of Genomic Medicine-SERGAS, Santiago de Compostela Clinic Hospital, Santiago de Compostela, Spain. ^[11]

关键词 EGFR gene mutation EGFR mutation testing EGFR tyrosine inhibitors TKIs epidermal growth factor receptor non-small-cell lung cancer

DOI 10.2147/CMAR.S85173

PMID 26893581

发布时间 2022-03-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交